POLYMED.BOPOLYMED.BOBSE
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+28.8%
5Y CAGR+22.7%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+28.8%/yr
vs +15.4%/yr prior
5Y CAGR
+22.7%/yr
Recent acceleration
Acceleration
+13.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.8x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$4.52B+26.4%
2024$3.58B+33.6%
2023$2.68B+26.4%
2022$2.12B-0.3%
2021$2.13B+30.7%
2020$1.63B+25.0%
2019$1.30B+8.9%
2018$1.20B+29.6%
2017$922.01M+7.5%
2016$857.76M-